Hedgehog pathway inhibitors promote adaptive immune responses in basal cell carcinoma

Clinical Cancer Research

Volumn 21, Issue 6, 2015, Pages 1289-1297

  Otsuka, Atsushi ^a   Dreier, Jil ^a   Cheng, Phil F ^a   Nägeli, Mirjam ^a   Lehmann, Holger ^b   Felderer, Lea ^a   Frew, Ian J ^b   Matsushita, Shigeto ^a,c   Levesque, Mitchell P ^a   Dummer, Reinhard ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c NATIONAL HOSPITAL ORGANIZATION KAGOSHIMA MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE; CYTOKINE; HLA DR2 ANTIGEN; KI 67 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROSTAGLANDIN E RECEPTOR 4; PROTEIN BCL 2; SONIC HEDGEHOG PROTEIN; SONIDEGIB; TRANSCRIPTION FACTOR SOX9; TUBULIN; VISMODEGIB; ANILIDE; BIPHENYL DERIVATIVE; G PROTEIN COUPLED RECEPTOR; HLA DR ANTIGEN; PYRIDINE DERIVATIVE; SMO PROTEIN, HUMAN;

ADAPTIVE IMMUNITY; ARTICLE; BASAL CELL CARCINOMA; CELL INVASION; CELL MEMBRANE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG EFFECT; DRUG RESPONSE; EUKARYOTIC FLAGELLUM; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOMODULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYSTEMIC THERAPY; TUMOR MICROENVIRONMENT; TUMOR REGRESSION; UPREGULATION; AGED; ANTAGONISTS AND INHIBITORS; BIOPSY; BIOSYNTHESIS; CARCINOMA, BASAL CELL; CD4+ T LYMPHOCYTE; DRUG EFFECTS; FEMALE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; VERY ELDERLY;

ADAPTIVE IMMUNITY; AGED; AGED, 80 AND OVER; ANILIDES; BIOPSY; BIPHENYL COMPOUNDS; CARCINOMA, BASAL CELL; CD4-POSITIVE T-LYMPHOCYTES; CILIA; CYTOKINES; FEMALE; HEDGEHOG PROTEINS; HLA-DR ANTIGENS; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; PYRIDINES; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 84927030619     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-14-2110     Document Type: Article

References (32)

1. Dreier J, Cheng PF, Bogdan Alleman I, Gugger A, Hafner J, Tschopp A, et al. Basal cell carcinomas in a tertiary referral centre: a systematic analysis. Br J Dermatol 2014;171:1066-72.
2. Walter A, Barysch MJ, Behnke S, Dziunycz P, Schmid B, Ritter E, et al. Cancer-testis antigens and immunosurveillance in human cutaneous squamous cell and basal cell carcinomas. Clin Cancer Res 2010;16:3562-70.
3. Von Hoff DD, LoRusso PM, Rudin CM, Reddy JC, Yauch RL, Tibes R, et al. Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N Engl J Med 2009;361:1164-72.
4. Rodon J, Tawbi HA, Thomas AL, Stoller RG, Turtschi CP, Baselga J, et al. A phase I, multicenter, open-label, first-in-human, dose-escalation study of the oral smoothened inhibitor Sonidegib (LDE225) in patients with advanced solid tumors. Clin Cancer Res 2014;20:1900-9.
5. Sekulic A, Migden MR, Oro AE, Dirix L, Lewis KD, Hainsworth JD, et al. Efficacy and safety of vismodegib in advanced basal-cell carcinoma.NEngl J Med 2012;366:2171-9.
6. Tang JY, Mackay-Wiggan JM, Aszterbaum M, Yauch RL, Lindgren J, Chang K, et al. Inhibiting the hedgehog pathway in patients with the basal-cell nevus syndrome. N Engl J Med 2012;366:2180-8.
7. Varjosalo M, Taipale J. Hedgehog: functions and mechanisms. Genes Dev 2008;22:2454-72.
8. Johnson RL, Rothman AL, Xie J, Goodrich LV, Bare JW, Bonifas JM, et al. Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 1996;272:1668-71.
9. Wong SY, Reiter JF. The primary cilium at the crossroads of mammalian hedgehog signaling. Curr Top Dev Biol 2008;85:225-60.
10. Corbit KC, Aanstad P, Singla V, Norman AR, Stainier DY, Reiter JF. Vertebrate smoothened functions at the primary cilium. Nature 2005;437:1018-21.
11. Rohatgi R,Milenkovic L, Scott MP. Patched1 regulates hedgehog signaling at the primary cilium. Science 2007;317:372-6.
12. Liao X, Siu MK, Au CW, Chan QK, Chan HY, Wong ES, et al. Aberrant activation of hedgehog signaling pathway contributes to endometrial carcinogenesis through beta-catenin. Mod Pathol 2009;22:839-47.
13. Hahn H, Wicking C, Zaphiropoulous PG, Gailani MR, Shanley S, Chidambaram A, et al. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 1996;85: 841-51.
14. Xie J, Murone M, Luoh SM, Ryan A, Gu Q, Zhang C, et al. Activating smoothened mutations in sporadic basal-cell carcinoma. Nature 1998;391:90-2.
15. Grob JJ, Kunstfeld R, Dreno B, Jouary T, Mortier L, Basset-Seguin N. Vismodegib, a Hedgehog pathway inhibitor (HPI), in advanced basal cell carcinoma (aBCC): STEVIE study interim analysis in 300 patients. J Clin Oncol 2013;31:9036.
16. Kaporis HG, Guttman-Yassky E, Lowes MA, Haider AS, Fuentes-Duculan J, Darabi K, et al. Human basal cell carcinoma is associated with Foxp3+ T cells in a Th2 dominant microenvironment. J Invest Dermatol 2007;127: 2391-8.
17. Wong SY, Seol AD, So PL, Ermilov AN, Bichakjian CK, Epstein EH Jr, et al. Primary cilia can both mediate and suppress Hedgehog pathway-dependent tumorigenesis. Nat Med 2009;15:1055-61.
18. Rowbotham NJ, Hager-Theodorides AL, Cebecauer M, Shah DK, Drakopoulou E, Dyson J, et al. Activation of the Hedgehog signaling pathway in Tlineage cells inhibits TCR repertoire selection in the thymus and peripheral T-cell activation. Blood 2007;109:3757-66.
19. Rowbotham NJ, Hager-Theodorides AL, Furmanski AL, Crompton T. A novel role for Hedgehog in T-cell receptor signaling: implications for development and immunity. Cell Cycle 2007;6:2138-42.
20. Rowbotham NJ, Furmanski AL, Hager-Theodorides AL, Ross SE, Drakopoulou E, Koufaris C, et al. Repression of hedgehog signal transduction in T-lineage cells increases TCR-induced activation and proliferation. Cell Cycle 2008;7:904-8.
21. Nestle FO, Burg G, Fah J, Wrone-Smith T, Nickoloff BJ. Human sunlightinduced basal-cell-carcinoma-associated dendritic cells are deficient in T cell co-stimulatory molecules and are impaired as antigen-presenting cells. Am J Pathol 1997;150:641-51.
22. Ichimura M, Hiratsuka K, Ogura N, Utsunomiya T, Sakamaki H, Kondoh T, et al. Expression profile of chemokines and chemokine receptors in epithelial cell layers of oral lichen planus. J Oral Pathol Med 2006;35: 167-74.
23. Lkhagvasuren E, Sakata M, Ohigashi I, Takahama Y. Lymphotoxin beta receptor regulates the development of CCL21-expressing subset of postnatal medullary thymic epithelial cells. J Immunol 2013;190: 5110-7.
24. Huang W,HuK, Luo S, ZhangM, Li C, Jin W, et al. Herpes simplex virus type 2 infection of human epithelial cells induces CXCL9 expression and CD4+T cell migration via activation of p38-CCAAT/enhancer-binding proteinbeta pathway. J Immunol 2012;188:6247-57.
25. Yuan R, Chen Y, He X, Wu X, Ke J, Zou Y, et al. CCL18 as an independent favorable prognostic biomarker in patients with colorectal cancer. J Surg Res 2013;183:163-9.
26. Zou Y, Chen Y, Wu X, Yuan R, Cai Z, He X, et al. CCL21 as an independent favorable prognostic factor for stage III/IV colorectal cancer. Oncol Rep 2013;30:659-66.
27. Zhou F. Molecularmechanisms of IFN-γ to up-regulate MHC class I antigen processing and presentation. Int Rev Immuno 2009;28:239-60.
28. Laner-Plamberger S, Wolff F, Kaser-Eichberger A, Swierczynski S, Hauser-Kronberger C, Frischauf AM, et al. Hedgehog/GLI signaling activates suppressor of cytokine signaling 1 (SOCS1) in epidermal and neural tumor cells. PLoS One 2013;8:e75317.
29. Otsuka A, Nakajima S, Kubo M, Egawa G, Honda T, Kitoh A, et al. Basophils are required for the induction of Th2 immunity to haptens and peptide antigens. Nat Commun 2013;4:1739.
30. Kitagaki H, Ono N, Hayakawa K, Kitazawa T, Watanabe K, Shiohara T. Repeated elicitation of contact hypersensitivity induces a shift in cutaneous cytokine milieu from a T helper cell type 1 to a T helper cell type 2 profile. J Immunol 1997;159:2484-91.
31. Mak KK, Bi Y, Wan C, Chuang PT, Clemens T, Young M, et al. Hedgehog signaling in mature osteoblasts regulates bone formation and resorption by controlling PTHrP and RANKL expression. Dev Cell 2008;14:674-88.
32. Deschaseaux F, Gaillard J, Langonné A, Chauveau C, Naji A, Bouacida A, et al. Regulation and function of immunosuppressive molecule human leukocyte antigen G5 in human bone tissue. FASEB J 2013;27:2977-87.